The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study

Chathuri Yatawara,1 Fatin Zahra Zailan,1 Esther Vanessa Chua,1 Linda Lay Hoon Lim,1 Eveline Silva,1 Joanna Sihan Wang,1 Adeline Ng,1 Kok Pin Ng,1 Nagaendran Kandiah1– 3 1Department of Neurology, National Neuroscience Institute, Singapore, Singapore; 2Duke-NUS Medical School, Singapore, Sin...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yatawara C, Zailan FZ, Chua EV, Lim LLH, Silva E, Wang JS, Ng A, Ng KP, Kandiah N
Format: article
Langue:EN
Publié: Dove Medical Press 2021
Sujets:
rivastigmine
alzheimer’s disease
small vessel cerebrovascular disease
treatment
Geriatrics
RC952-954.6
Accès en ligne:https://doaj.org/article/77088d6a53fd4ec4be41f84146f8313f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/77088d6a53fd4ec4be41f84146f8313f

Documents similaires